Expression of Prostaglandin E2 Receptors in Acquired Middle Ear Cholesteatoma

키워드

참고문헌 (29)

1. Olszewska E, "Etiopathogenesis of cholesteatoma", Eur Arch Otorhinolaryngol, 261(1), pp.6~24 (2004)[DOI]
2. Steven K. Juhn, "The Role of Inflammatory Mediators in the Pathogenesis of Otitis Media and Sequelae", Clinical and Experimental Otorhinolaryngology, 1(3), pp.117~138 (2008), 대한이비인후과학회
3. Liu W, "Activation of the IL-6", JAK, Int J Clin Exp Pathol, pp.2014, 7(2)[DOI]
4. Sakuma Y, "Crucial involvement of the EP4 subtype of prostaglandin E receptor in osteoclast formation by proinflammatory cytokines and lipopolysaccharide", J Bone Miner Res, 15(2), pp.218~227 (2000)
5. Jung TT, "Prostaglandins in human cholesteatoma and granulation tissue", Am J Otol, 9(3), pp.197~200 (1988)
6. Shirahata Y, "Experimental aural cholesteatoma causing bone resorption", Nihon Jibiinkoka Gakkai Kaiho, 84(11), pp.1451~1459 (1981)[DOI]
7. Hristovska AM, "Prostaglandin E2 induces vascular relaxation by E-prostanoid 4 receptor-mediated activation of endothelial nitric oxide synthase", Hypertension, 50(3), pp.525~530 (2007)[DOI]
8. Yokoyama U, "Chronic activation of the prostaglandin receptor EP4 promotes hyaluronan-mediated neointimal formation in the ductus arteriosus", J Clin Invest, 116(11), pp.3026~3034 (2006)[DOI]
9. Takayama K, "Prostaglandin E2 suppresses chemokine production in human macrophages through the EP4 receptor", J Biol Chem, 277(46), pp.44147~44154 (2002)[DOI]
10. Kabashima K, "The prostaglandin receptor EP4 suppresses colitis, mucosal damage and CD4 cell activation in the gut", J Clin Invest, 109(7), pp.883~893 (2002)[DOI]
11. Nitta M, "Expression of the EP4 prostaglandin E2 receptor subtype with rat dextran sodium sulphate colitis: colitis suppression by a selective agonist, ONO-AE1-329", Scand J Immunol, 56(1), pp.66~75 (2002)[DOI]
12. Jee WS, "The effects of prostaglandin E2 in growing rats: increased metaphyseal hard tissue and cortico-endosteal bone formation", Calcif Tissue Int, 37(2), pp.148~157 (1985)[DOI]
13. Jee WS, "The role of bone cells in increasing metaphyseal hard tissue in rapidly growing rats treated with prostaglandin E2", Bone, 8(3), pp.171~178 (1987)[DOI]
14. Li XJ, "Transient effects of subcutaneously administered prostaglandin E2 on cancellous and cortical bone in young adult dogs", Bone, 11(5), pp.353~364 (1990)[DOI]
15. Chyun YS, "Stimulation of bone formation by prostaglandin E2", Prostaglandins, 27(1), pp.97~103 (1984)
16. Nagata T, "Effect of prostaglandin E2 on mineralization of bone nodules formed by fetal rat calvarial cells", Calcif Tissue Int, 55(6), pp.451~457 (1994)[DOI]
17. Alander CB, "Effects of selective prostaglandins E2 receptor agonists on cultured calvarial murine osteoblastic cells", Prostaglandins Other Lipid Mediat, 81(3-4), pp.178~183 (2006)[DOI]
18. Shamir D, "A selective EP4 receptor antagonist abrogates the stimulation of osteoblast recruitment from bone marrow stromal cells by prostaglandin E2 in vivo and in vitro", Bone, 34(1), pp.157~162 (2004)[DOI]
19. Weinreb M, "Prostaglandin E2 (PGE2) increases the number of rat bone marrow osteogenic stromal cells (BMSC) via binding the EP4 receptor, activating sphingosine kinase and inhibiting caspase activity", Prostaglandins Leukot Essent Fatty Acids, 75(2), pp.81~90 (2006)[DOI]
20. Machwate M, "Prostaglandin receptor EP(4) mediates the bone anabolic effects of PGE(2)", Mol Pharmacol, 60(1), pp.36~41 (2001)[DOI]
21. Lader CS, "Prostaglandin E2, interleukin 1alpha, and tumor necrosis factor-alpha increase human osteoclast formation and bone resorption in vitro", Endocrinology, 139(7), pp.3157~3164 (1998)[DOI]
22. Sarrazin P, "Characterization of the prostaglandin receptors in human osteoblasts in culture", Prostaglandins Leukot Essent Fatty Acids, 64(3), pp.203~210 (2001)[DOI]
23. Mano M, "Prostaglandin E2 directly inhibits bone-resorbing activity of isolated mature osteoclasts mainly through the EP4 receptor", Calcif Tissue Int, 67(1), pp.85~92 (2000)[DOI]
24. Yoshida K, "Stimulation of bone formation and prevention of bone loss by prostaglandin E EP4 receptor activation", Proc Natl Acad Sci U S A, 99(7), pp.4580~4585 (2002)[DOI]
25. Iino Y, "Cholesteatoma debris as an activator of human monocytes: potentiation of the production of tumor necrosis factor", Acta Otolaryngol, 110(5-6), pp.410~415 (1990)[DOI]
26. Xie L, "Expression profiles of prostaglandin E2 receptor subtypes in aspirin tolerant adult Chinese with chronic rhinosinusitis", Am J Rhinol Allergy, 29(5), pp.322~328 (2015)[DOI]
27. Morimoto K, "Prostaglandin E2-EP3 signaling induces inflammatory swelling by mast cell activation", J Immunol, 192(3), pp.1130~1137 (2014)[DOI]
28. Sakanaka M, "Essential role of EP3 subtype in prostaglandin E2-induced adhesion of mouse cultured and peritoneal mast cells to the Arg-Gly-Asp-enriched matrix", Am J Physiol Cell Physiol, 295(5), pp.C1427~C1433 (2008)[DOI]
29. Minamizaki T, "EP2 and EP4 receptors differentially mediate MAPK pathways underlying anabolic actions of prostaglandin E2 on bone formation in rat calvaria cell cultures", Bone, 44(6), pp.1177~1185 (2009)[DOI]

관련 논문AI추천